Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Heliyon ; 8(3): e09060, 2022 Mar.
Article in English | MEDLINE | ID: mdl-35284681

ABSTRACT

This research aimed to investigate the present status of disease prevalence and usage of aqua drugs for various aquaculture operations in the Narsingdi region of Bangladesh. Data were collected through the market survey, preset questionnaire interview, personal contact, and participatory rural appraisal tools. Amongst the respondents, the maximum percentages were found practicing mixed cultures of carp, tilapia, and pangas. The respondents suggested that epizootic ulcerative syndrome, saprolegniasis, streptococcosis, tail and fin rot and bacillary necrosis are common fish diseases in the area. About 140 drugs of different companies used in aquaculture for different purposes such as disease treatment, growth enhancement, water quality improvement, toxic gas removal, improvement of feed conversion ratio. Zeolite, rotenone, disinfectant, oxygen precursors, ammonia reducers, and probiotics were applied for pond preparation, water, and soil quality maintenance, while 30 different antibiotics were used for the purpose of treatment. Among the available antibiotics, oxytetracycline, ciprofloxacin, enrofloxacin, erythromycin, sulphadiazine, and trimethoprim were found extensively used by the fish farmers. Four enzymes and eighteen growth promoters were identified as being utilized to enhance digestion and boost up the production. This study elicited various issues connected with application and administration of such aqua chemicals, including farmers' ignorance about their usage, proper doses, application methods, withdrawal period, and the human health concerns associated with their irresponsible use. However, the consequences of these chemical products to the environment, animal health, and human health required further study for the betterment of mankind.

2.
Biomark Med ; 14(14): 1371-1382, 2020 10.
Article in English | MEDLINE | ID: mdl-33064013

ABSTRACT

Aim: To evaluate the expression pattern of ALDH1 (aldehyde dehydrogenase 1), E-cadherin, Vimentin and Twist in early and late onset sporadic colorectal cancer (CRC) and to study association of their expression with the occurrence of CRC at a young age. Materials & methods: Immunohistochemistry of ALDH1, E-cadherin, Vimentin and Twist was performed on 103 pretreated CRC biopsy samples. Results: ALDH1 expression was found to have strong correlation with early onset CRC (p < 0.0001). Conclusion: High ALDH1 expression correlates with the early onset of CRC. ALDH1 over-expression correlates with poor overall survival in colon cancer.


Subject(s)
Aldehyde Dehydrogenase 1 Family/metabolism , Cadherins/metabolism , Colorectal Neoplasms/metabolism , Gene Expression Regulation, Neoplastic , Twist-Related Protein 1/metabolism , Vimentin/metabolism , Adult , Female , Humans , Male , Middle Aged , Survival Analysis
3.
Asian Pac J Cancer Prev ; 16(16): 7161-5, 2015.
Article in English | MEDLINE | ID: mdl-26514506

ABSTRACT

BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is a common cancer in the north east of India. The present study concerned the prevalence of human papilloma virus (HPV) in the ESCC in north eastern India and its impact on response to chemotherapy. MATERIALS AND METHODS: p16 expression, a surrogate marker for HPV infection was assessed in 101 pre-treatment biopsies of locally advanced ESCC, reported from a comprehensive cancer centre in north east India, using immunohistochemistry. All patients received neo-adjuvant chemotherapy. Response was assessed clinically and histopathologically with attention to p16 expression. RESULTS: p16 was expressed in 22% of ESCC (22 out of 101) and was more prevalent in patients who were more than 45 years of age (P=0.048). p16 positive tumors appeared more commonly in the upper 2/3 of the thoracic esophagus (18 in 22). Nine of the 22 (41%) p16 positive tumors achieved pathologic complete response following neo-adjuvant chemotherapy (P=0.008). There was a trend towards reduced mortality in this group (P=0.048). Some 9 of the 20 (45%) patients who achieved pathologic complete response were p16 positive. CONCLUSIONS: Expression of p16 in ESCC correlates with higher rate of pathologic complete remission in patients undergoing neo adjuvant chemotherapy and could be a predictive marker for response assessment.


Subject(s)
Biomarkers, Tumor/analysis , Carcinoma, Squamous Cell/chemistry , Carcinoma, Squamous Cell/drug therapy , Esophageal Neoplasms/chemistry , Esophageal Neoplasms/drug therapy , Neoplasm Proteins/analysis , Papillomavirus Infections/epidemiology , Adult , Age Factors , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Squamous Cell/pathology , Chemotherapy, Adjuvant , Cyclin-Dependent Kinase Inhibitor p16 , Esophageal Neoplasms/pathology , Female , Humans , India/epidemiology , Male , Middle Aged , Neoadjuvant Therapy , Papillomavirus Infections/metabolism , Predictive Value of Tests , Prevalence , Remission Induction , Retrospective Studies , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...